Comparison of The Antiglycation Effect of Pyridoxamine and Nettle Hydroalcoholic Extract on Albumin
DOI:
https://doi.org/10.46966/msjar.v5i4.234Keywords:
Pyridoxamine, Nettle extract, Antiglycation, Human serum albumin, and DiabetesAbstract
Background: Free radicals are highly reactive molecules that cause oxidative damage to fats, proteins, and nucleic acids. Therefore, they play a crucial role in the development of many diseases such as heart disease, cancer, and abnormal brain function. The human body is equipped with antioxidants that neutralize free radicals, preventing their accumulation in tissues. The imbalance between the production of these radicals and the level of antioxidants leads to oxidative stress, where an increase in free radical production reduces antioxidant levels, causing a deficiency in the body. On the other hand, evidence indicates that oxidative stress contributes to the onset and exacerbation of diabetes-related complications and plays a significant role in non-enzymatic glycation of proteins (Riahi et al., 2014). Therefore, any diabetes treatment must directly or indirectly reduce non-enzymatic protein glycation and oxidative stress. Non-enzymatic protein glycation and the formation of AGEs are factors involved in the pathogenesis of chronic diabetes complications. Since glycation reactions are accompanied by oxidation reactions, leading to the improper function of proteins, plant-derived antioxidant compounds can be used as a therapeutic approach to prevent the onset of these chronic complications.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mohammed Abbas Al-Silaykhee

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















